Uric Acid in Parkinson's Disease
Identifieur interne : 003636 ( Main/Merge ); précédent : 003635; suivant : 003637Uric Acid in Parkinson's Disease
Auteurs : Ilana Schlesinger [Israël] ; Naomi Schlesinger [États-Unis]Source :
- Movement disorders [ 0885-3185 ] ; 2008.
Descripteurs français
- Pascal (Inist)
English descriptors
Abstract
Recent studies have provided evidence that uric acid may play a role in the development and progression of Parkinson's disease (PD). Uric acid is a natural antioxidant that may reduce oxidative stress, a mechanism thought to play a role in the pathogenesis of PD. Higher levels of serum urate (SU) may have a neuroprotective effect. High SU levels reduced the risk of developing PD and correlated with slower PD progression. Among PD patients SU levels were lower as compared with controls. The manipulation of SU levels holds promise in the treatment of PD. It is possible that a high purine diet in patients with PD may slow progression of the disease. Milk and meat consumption as well as exercise modify the risk of developing PD possibly through their influence on SU levels. In this article, we review the association between PD and SU levels and its implication on the management of PD.
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 001122
- to stream PascalFrancis, to step Curation: 001B97
- to stream PascalFrancis, to step Checkpoint: 001028
Links to Exploration step
Pascal:08-0487365Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Uric Acid in Parkinson's Disease</title><author><name sortKey="Schlesinger, Ilana" sort="Schlesinger, Ilana" uniqKey="Schlesinger I" first="Ilana" last="Schlesinger">Ilana Schlesinger</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Head, Movement Disorders Clinic, Rambam Health Care Campus</s1><s2>Haifa</s2><s3>ISR</s3><sZ>1 aut.</sZ></inist:fA14><country>Israël</country><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Schlesinger, Naomi" sort="Schlesinger, Naomi" uniqKey="Schlesinger N" first="Naomi" last="Schlesinger">Naomi Schlesinger</name><affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Division of Rheumatology, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School</s1><s2>New Brunswick, New Jersey</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">New Jersey</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">08-0487365</idno><date when="2008">2008</date><idno type="stanalyst">PASCAL 08-0487365 INIST</idno><idno type="RBID">Pascal:08-0487365</idno><idno type="wicri:Area/PascalFrancis/Corpus">001122</idno><idno type="wicri:Area/PascalFrancis/Curation">001B97</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001028</idno><idno type="wicri:doubleKey">0885-3185:2008:Schlesinger I:uric:acid:in</idno><idno type="wicri:Area/Main/Merge">003636</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Uric Acid in Parkinson's Disease</title><author><name sortKey="Schlesinger, Ilana" sort="Schlesinger, Ilana" uniqKey="Schlesinger I" first="Ilana" last="Schlesinger">Ilana Schlesinger</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Head, Movement Disorders Clinic, Rambam Health Care Campus</s1><s2>Haifa</s2><s3>ISR</s3><sZ>1 aut.</sZ></inist:fA14><country>Israël</country><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Schlesinger, Naomi" sort="Schlesinger, Naomi" uniqKey="Schlesinger N" first="Naomi" last="Schlesinger">Naomi Schlesinger</name><affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Division of Rheumatology, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School</s1><s2>New Brunswick, New Jersey</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">New Jersey</region></placeName></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2008">2008</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Nervous system diseases</term><term>Parkinson disease</term><term>Uric acid</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term><term>Pathologie du système nerveux</term><term>Acide urique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Recent studies have provided evidence that uric acid may play a role in the development and progression of Parkinson's disease (PD). Uric acid is a natural antioxidant that may reduce oxidative stress, a mechanism thought to play a role in the pathogenesis of PD. Higher levels of serum urate (SU) may have a neuroprotective effect. High SU levels reduced the risk of developing PD and correlated with slower PD progression. Among PD patients SU levels were lower as compared with controls. The manipulation of SU levels holds promise in the treatment of PD. It is possible that a high purine diet in patients with PD may slow progression of the disease. Milk and meat consumption as well as exercise modify the risk of developing PD possibly through their influence on SU levels. In this article, we review the association between PD and SU levels and its implication on the management of PD.</div></front></TEI><affiliations><list><country><li>Israël</li><li>États-Unis</li></country><region><li>New Jersey</li></region></list><tree><country name="Israël"><noRegion><name sortKey="Schlesinger, Ilana" sort="Schlesinger, Ilana" uniqKey="Schlesinger I" first="Ilana" last="Schlesinger">Ilana Schlesinger</name></noRegion></country><country name="États-Unis"><region name="New Jersey"><name sortKey="Schlesinger, Naomi" sort="Schlesinger, Naomi" uniqKey="Schlesinger N" first="Naomi" last="Schlesinger">Naomi Schlesinger</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003636 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003636 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Merge
|type= RBID
|clé= Pascal:08-0487365
|texte= Uric Acid in Parkinson's Disease
}}
| This area was generated with Dilib version V0.6.23. |  |